Title : Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion - Kalra_2014_Cancer.Res_74_7003 |
Author(s) : Kalra AV , Kim J , Klinz SG , Paz N , Cain J , Drummond DC , Nielsen UB , Fitzgerald JB |
Ref : Cancer Research , 74 :7003 , 2014 |
Abstract : Kalra_2014_Cancer.Res_74_7003 |
ESTHER : Kalra_2014_Cancer.Res_74_7003 |
PubMedSearch : Kalra_2014_Cancer.Res_74_7003 |
PubMedID: 25273092 |